ClinicalTrials.gg
CompletedNCT07234994Updated May 22, 2026

Comparison of the Effect of Ozonized Gel to That of Photobiomodulation Therapy on Wound Healing Following Surgical Gingivectomy

An interventional study of ozonized gel application and photobiomodulation therapy using diode laser in Gingival Enlargement, sponsored by Mennatullah osama ahmed zaki wahba. Completed at 1 site in Egypt. Open to participants aged 18 Years to 40 Years. Per ClinicalTrials.gov, last updated 2026-05-22.

Sponsored by Mennatullah osama ahmed zaki wahba · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
48
Allocation
Randomized
Ages
18 Years to 40 Years
Sex
All
01

Study summary

The goal of this clinical trial is to compare the effect of photobiomodulation to ozonized gel on wound healing following gingivectomy procedure on adults. The main questions it aims to answer are:

Which treatment modality provides less painful and more efficient wound healing ? What are the patient's feedback on different treatment modalities ? Researchers will compare ozonized gel to photobiomodulation to normal gingivectomy procedure with no interference.

Participants will:

Receive either ozonized gel or photobiomodualtion treatment following surgical gingivectomy Visit the clinic every 3,7,14 and 28 days for checkups and investigations

Read the detailed description

Surgical gingivectomy is performed for elimination of supra bony pockets and gingival enlargements and it can be considered the gold standard treatment for such cases. The healing of wound site after gingivectomy occurs slowly by secondary intention; therefore, several studies have been conducted evaluating the effect of various treatment modalities to accelerate the process of wound healing such as use of ozonized gel and photobiomodulation. Ozone, owing to its biocompatibility, healing, and antimicrobial properties, is used for wound healing and tissue repair. Photobiomodulation Therapy (PBMT) using diode laser is another treatment modality regarded as an effective modality for the repair of tissues, control of pain and wound healing. This study will be carried out to clinically compare and evaluate the healing of surgical gingivectomy wounds using ozonized gel and PBMT.

Aim: Compare the efficacy of the ozonized gel to photobiomodulation therapy in wound healing following surgical gingivectomy Materials and Methods: This randomized controlled clinical trial will involve 48 surgical gingivectomy wound sites, equally divided into three groups, Group-I (test group1): ozonized hydrogel will be applied to raw wound area following surgical gingivectomy and at days 3,7,14 post surgery. Group II (test group 2): the surgical site will be irradiated with a diode laser (635 nm) directly following surgery and at days 3,7,14 postoperative. Group III (control group) will include surgical gingivectomies that will be left to heal spontaneously. Wound healing will be assessed using Landry's Healing index and by measuring degree of epithelialization, and pain level will be assessed using a Visual analog scale on the 3rd, 7th, 14th, and 28th days after surgery.

02

Conditions studied

  • Gingival Enlargement

Keywords

  • Ozonized gel
  • Photobiomodulation Therapy
  • Surgical gingivectomy
  • Wound healing
03

In context

Lead sponsor

This is the only study on the registry with Mennatullah osama ahmed zaki wahba as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Patients indicated for surgical gingivectomy.
  2. Adequate amount of keratinized tissue.
  3. Average age between 18-40 years.
  4. Well-educated patients as post-operative instructions need to be followed precisely.
  5. Good oral hygiene with a full mouth O'Leary plaque index of less than or equal to 10% and a full mouth Gingival Index of zero

Exclusion criteria

Exclusion Criteria:

  1. History of smoking.
  2. Patients who have any known systemic disease that interfere with performance of surgical gingivectomy or periodontal wound healing.
  3. Patients who have any previous adverse reactions to the products (or similar products) used in this study.
  4. Pregnant women.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
48 participants (actual)

Study arms

  • Active comparator
    Ozonized gel group

    Application of ozonized gel to raw wound area following surgical gingivectomy.

    Drug: ozonized gel application

  • Active comparator
    Photobiomodulation therapy group

    Application of diode laser 635nm to wound area following surgical gingivectomy

    Device: photobiomodulation therapy using diode laser

  • No intervention
    Control group

    Spontaneous healing of wound area following surgical gingivectomy

Interventions

  • Drugozonized gel application

    Application of ozonized gel to raw wound area following surgical gingivectomy.

  • Devicephotobiomodulation therapy using diode laser

    Application of diode laser 635nm to wound area following surgical gingivectomy

06

What researchers measure

Primary outcomes

  1. Healing index (HI) using Landry index

    The healing index (HI) scores will be assessed on the basis of redness, presence of granulation tissues, bleeding, suppuration, and epithelialization.

    Time frame: day 3,7,14,28 post surgical gingivectomy

  2. Evaluation of epithelialization of the wound area

    A plaque disclosing agent is used to measure wound area epithelialization by dying the abraded and deepithelialized areas on the gingiva on postoperative days 3,7,14 and 28. By using this solution, assessment of degree of epithelialization and wound healing is made easier. Wound surface epithelialization in the obtaining photographs will be evaluated using an Image-analyzing software. To ensure standardization, all photographs will taken by the same person with the same camera at the same angle.

    Time frame: days 0,3,7,14,28 post surgical gingivectomy

  3. Postoperative pain using the VAS

    Visual Analogue Scale (VAS) is a simple measurement tool that measures the intensity of pain as recorded by the patient. 10-point visual analog scale of pain rating, with 0 marked as "no pain" and 10 marked as "worst pain imaginable

    Time frame: day 0. day 3, day 7, and day 14 post surgery.

Secondary outcomes

  1. Gingival crevicular fluid sampling for Vascular Endothelial Growth Factor quantification

    Vascular Endothelial Growth Factor (VEGF) was analyzed from gingival crevicular fluid (GCF) at baseline, days 7, 14, and 28 for biochemical analysis using ELISA kit.

    Time frame: baseline(day 0), day 7,day14 and day 28 post gingivectomy

07

Study locations

1 site
  • Faculty of Dentistry, Alexandria University
    Alexandria, 5310002, Egypt
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Nov 2025 to primary completion in Mar 2026, 3 months.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 16, 2025
First posted
Nov 19, 2025
StartActual
Nov 16, 2025
Primary completionActual
Mar 15, 2026
CompletionActual
Mar 30, 2026
Last update
May 22, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 22, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07234994
Lead sponsor
Mennatullah osama ahmed zaki wahba
Responsible party
Mennatullah osama ahmed zaki wahba (Dentist, Alexandria University) — Sponsor-investigator
First posted
Nov 19, 2025
Start date
Nov 16, 2025
Primary completion
Mar 15, 2026
Completion
Mar 30, 2026
Last update
May 22, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion